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Since the founding of the People’s Republic of China in 1949, considerable progress has been made in the
control and elimination of the country’s initial set of 11 neglected tropical diseases. Indeed, elimination as a
public health problem has been declared for lymphatic filariasis in 2007 and for trachoma in 2015. The
remaining numbers of people affected by soil-transmitted helminth infection, clonorchiasis, taeniasis, and
echinococcosis in 2015 were 29.1 million, 6.0 million, 366 200, and 166 100, respectively. In 2017, after more
than 60 years of uninterrupted, multifaceted schistosomiasis control, has seen the number of cases dwindling
from more than 10 million to 37 600. Meanwhile, about 6000 dengue cases are reported, while the incidence
of leishmaniasis, leprosy, and rabies are down at 600 or fewer per year. Sustained social and economic
development, going hand-in-hand with improvement of water, sanitation, and hygiene provide the
foundation for continued progress, while rigorous surveillance and specific public health responses will
consolidate achievements and shape the elimination agenda. Targets for poverty elimination and strategic
plans and intervention packages post-2020 are important opportunities for further control and elimination,
when remaining challenges call for sustainable efforts.
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Please see Additional file 1 for translations of the
abstract into the five official working languages of the
United Nations.Background
The term “neglected tropical diseases” (NTDs in short)
was coined some 15 years ago, referring to a diverse
group of diseases that are intimately linked to poverty
and primarily occur in tropical and subtropical coun-
tries, affecting marginalized communities in rural and© The Author(s). 2019 Open Access This artic
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Full list of author information is available at the end of the articledeprived urban settings [1, 2]. In the meantime, consid-
erable progress has been made in the control of NTDs
with some of them having been targeted for elimination
[3]. Yet, the NTDs remain a public health problem and
drain the social and economic development in many
parts of the world [4].
In its first report issued in 2010, the World Health
Organization (WHO) listed 17 NTDs [5]. In the mean-
time, the list has been expanded to 20 NTDs, which are
caused by a diverse set of agents, such as bacteria, para-
sites, and virus, in addition to snakebites [6]. Over a bil-
lion people are affected by one or several NTDs,
primarily in low- and middle-income countries (LMICs)
[4, 6]. Most of the NTDs are tracked by the Global Bur-
den of Diseases (GBD) Study, and hence, their global
burden, as expressed in disability-adjusted life years
(DALYs), is updated annually. Taken together, the globalle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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DALYs [7] .
In 2012, WHO released a roadmap for the control and
elimination of the NTDs, which included specific mile-
stones for achieving set goals [8]. Inspired by this road-
map, the London Declaration was released in the same
year and several institutions, foundations, philanthropic
organisations, and pharmaceutical companies pledged
support to foster research and development on NTDs,
and to assist WHO to work with endemic countries,
non-governmental organisations (NGOs), and influential
politicians towards control and elimination of 10 NTDs
(i.e. eradication of Guinea worm; elimination as a public
health problem of lymphatic filariasis, leprosy, human
African trypanosomiasis, and blinding trachoma; and
control of schistosomiasis, soil-transmitted helminth
infection, Chagas disease, visceral leishmaniasis, and
onchocerciasis by 2020) [9]. Reports note that, despite
existing challenges, the potential to accelerate progress
towards Universal Health Coverage (UHC) remains in
place with endorsement by WHO [3, 10, 11]. Integration
of activities and interventions into broader health sys-
tems is being promoted, and the agenda has been
advanced to 2030 [3].
Historically, many of the diseases discussed here have
dominated the public health agenda in the People’s
Republic of China. Eleven of the NTDs currently listed
by WHO have been and several continue to be endemic,
thus negatively impacting on people’s health and well-
being (Table 1). Yet, owing to sustained social and eco-
nomic development, going hand-in-hand with massive
control efforts, the influence of these NTDs have been
significantly reduced with some of them already elimi-
nated [12]. Indeed, the elimination of lymphatic filariasis
as a public health problem, achieved by the People’s
Republic of China as the first country in the world and
verified by WHO in 2007, is a major success story [13].
In 2015, the elimination of trachoma as a public health
problem followed suit [14], while substantial progress
has been made with respect to the remaining nine
NTDs. The government is committed to further
strengthen control activities and move towards elimina-
tion of most of the remaining NTDs by or beyond 2020.
Clearly, experiences and lessons from the People’s
Republic of China are relevant for the control and elimi-
nation of NTDs elsewhere [15]. To that end, we review
here the progress and milestones of the control and
elimination of NTDs since the foundation of the People’s
Republic of China exactly 70 years ago, at the onset of
the Belt and Road Initiative. The accomplishments with
reference to the achievement of targets expected by
2020 are summarised, the remaining challenges high-
lighted, and opportunities for sustained control and
elimination of the NTDs emphasised.Progress in the control and elimination of NTDs in
the People’s Republic of China
Bacterial infections
Leprosy
About 500 000 leprosy cases were detected in the
People’s Republic of China between 1949 and 2017,
mainly in the south-western and south-eastern parts of
the country (Table 1 and Fig. 1a) [16–20]. The annual
detection rate of new cases exceeded 1 per 100 000
between 1954 and 1976, with a peak of 5.56 per 100 000
(34 878 cases in total) in 1958 [16]. At the initial control
stage, from the 1950s to 1980, an approach consisting of
detection, separation, and treatment was employed to
control the infection [21]. Incidence started to decline
already around 1970 and continued to drop. A second
phase began in 1981 with the stated aim to eliminate
leprosy, targeting a prevalence level of < 1 per 100 000 at
county level through early case detection and multidrug
therapy [21]. In 2017, an all-time low of 634 new cases
were reported, corresponding to a incidence of 0.05 per
100 000 (Fig. 2a and b) [20]. Meanwhile, the countrywide
prevalence reached 0.19 per 100 000 (2697 cases), with
most of the cases (n = 1643) concentrated in five pro-
vince in the southern part of the People’s Republic of
China [20].
In 2011, the “Programme on the elimination of leprosy
in China 2011–2020” was launched, promoting profes-
sional training, early detection, and regulatory treatment,
combined with setting-specific information, education,
and communication (IEC) [22]. Two specific targets
were included: (i) halving the total number of cases in
2010 by 2020 (i.e. 3300) and reducing the prevalence
below 1 per 100 000 in 98% counties [22]. The first tar-
get was already achieved in 2015 (i.e. 3230 cases) [19].
Trachoma
Before 1949, it was estimated that the prevalence of tra-
choma in the People’s Republic of China was about 50%,
with 25–37% of all blindness in the country caused by
this bacterial infection [23]. From 1956 onwards, tra-
choma control was prioritised by inclusion in the
National Programme of Agricultural Development
(1956–1967) [24], which encouraged hygienic measures,
such as regularly cleaning hands and faces with running
water and use of individual towels, among other public
health measures [23]. In 1990, the control of trachoma
became part of school health regulations [25]. The
“SAFE” strategy recommended by WHO was also gradu-
ally adopted, consisting of surgery for advanced disease
(S), antibiotics to clear Chlamydia trachomatis infection
(A), facial cleanliness (F), and environmental improve-
ment to reduce transmission (E). According to two national
disability surveys, the prevalence of blindness caused by tra-
choma decreased to 51.5 per 100 000 in 1987 and to 17.6
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Fig. 1 Endemicity of NTDs, stratified by province, in the People’s Republic of China. a Reported cases of leprosy, rabies, and visceral leishmaniasis
from passive surveillance (in 2017); b reported cases of dengue from passive surveillance (in 2017); c prevalence of echinococcosis, clonorchiasis,
soil-transmitted helminth infection, and taeniasis from national surveys (between 2012 and 2016); and d estimated cases of schistosomiasis (in
2017). NTDs: neglected tropical diseases
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blindness attributed to trachoma decreased to 10.1% and to
0.9%, respectively [26].
From September 2012 onwards, the goal “Eliminating
blinding trachoma in China before 2016” was promoted
[23]. Within two years, 8163 children under the age of
nine years in 130 schools, and 87 924 355 residents aged
15 years and above in 55 679 villages were surveyed in
16 provinces with a previously high trachoma incidence
[14]. The prevalence of active trachoma and trichiasis
(abnormally positioned eyelashes) decreased to 0.2% and
0.002%, respectively, thereby reaching the targets set by
WHO for elimination of trachoma as a public health
problem [14].
Viral infections
Dengue
Although dengue was endemic in the People’s
Republic of China before 1949, it disappeared for
nearly 30 years until an outbreak occurred in 1978 in
Guangdong province in the southern part of the
country, which affected 22 122 people [27]. In 1980,
another, even much larger outbreak hit Guangdong,affecting 452 674 individuals [27]. Overall, more than 660
000 people were infected in Guangdong between 1978
and 1991, causing 493 deaths [27]. This led to dengue
being included among the national notifiable diseases
from 1989 onwards. During 1990–2017, a total of 80 583
cases (including 13 deaths) were reported through the
health system (Fig. 2a) [20, 28, 29]. Although the situation
improved in the 1980s, indigenous cases expanded from
southern coastal tropical or subtropical regions to neigh-
bouring northern and western regions, reaching as far as
the central part of the People’s Republic of China (Table 1
and Fig. 1b) [28]. Additionally, imported cases (both from
domestic endemic areas and overseas) occurred with a
nationwide distribution [28]. Another large outbreak hit
Guangdong province in 2014, involving 45 224 cases and
six deaths [30].
It is conceivable that the pre-1978 disappearance of dengue
is attributable to effective mosquito control efforts facilitated
by Patriotic Health Campaigns [31]. Population mobilization,
imported cases, and vector multiplication caused sub-
sequent outbreaks. Surveillance, timely management
of cases, and control of vectors remain the key mea-
sures against dengue [32].
Fig. 2 Change trends of NTDs in the People’s Republic of China. a Reported cases of leprosy, rabies, visceral leishmaniasis, and dengue from
passive surveillance (1990–2017); b reported cases of leprosy, rabies, and visceral leishmaniasis from passive surveillance (1990–2017); c estimated
cases of echinococcosis, clonorchiasis, schistosomiasis, soil-transmitted helminth infection. and taeniasis from national surveys (1990s–2015); d
estimated cases of echinococcosis, schistosomiasis, and taeniasis from national surveys (1990s–2015); and e estimated cases of clonorchiasis from
national surveys (1990s–2015). NTDs: Neglected tropical diseases
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Rabies is primarily caused by dog bites (95%); yet, cat
bites also contribute (4%) [33]. From 1960 to 2017, a
total of 122 874 cases of rabies were reported in the
People’s Republic of China [20, 29, 34]. Between 1979
and 1989, over 4000 cases were reported every year, with
a peak in 1981 (7037 cases; 0.71 per 100 000) [34]. The
disease decreased gradually and reached its lowest level
in 1996 (159 cases; 0.01 per 100 000) [34]. However, it
increased once again reaching a peak in 2007 (3300
cases; 0.25 per 100 000) [33, 34] after which a gradual
decrease to 516 cases in 2017 was noted (Table 1, Fig. 2a
and b) [20, 29], with most cases found in the eastern
and southern regions (Fig. 1a). In spite of the recent
overall decrease, rabies expanded slightly in the western
and northern areas over the past 10 years. Rural areas
are most severely afflicted [34].
The fluctuating number of infections is explained by
multiple factors. For example, the increasing numbers of
household dogs without immunization and the transpor-
tation of dogs might explain the two peaks of rabies
noted in the 1980s and the 2000s. Investment in training
of health professionals and an increasing access to post-
exposure prophylaxis in rural areas led to the recent,
sustainable decrease [33]. The central government’s
mid- and long-term control strategy for epidemicdiseases in animals (2012–2020) requires national con-
trol of rabies by 2020, mainly promoted through dog
immunization [35]. In 2017, the Ministry of Agriculture
issued a national control plan (2017–2020), aiming at
strengthening rabies control by targeting coverage of
90% immunization of registered dogs in all counties by
2020 [36].
Protozoa infections
Leishmaniasis
Between 1951 and 1972, visceral leishmaniasis was ende-
mic in 16 provinces in the northern part of the People’s
Republic of China and along the Yangtze River with the
main endemic areas located in the plain region of the
central and eastern parts, the North China Plain and the
Central Shaanxi Plain [37]. A conservative estimate in
1951 indicated that 530 000 people were infected [37].
The disease was given a high priority and included in
the National Programme of Agricultural Development
1956–1967 [24]. Considerable efforts were made to con-
trol the disease, including the establishment of profes-
sional leishmaniasis control groups tasked with the
detection and treatment of patients and insecticide
spraying to eliminate the sand fly vector [37]. No new
cases were detected in the previously endemic plains
since 1983, but endemicity persisted in the hilly and
Qian et al. Infectious Diseases of Poverty            (2019) 8:86 Page 6 of 16desert areas of six western provinces (Fig. 1a) [37].
Additionally, imported cases were reported from other
provinces. For example, 3994 cases were reported
from 27 provinces in the period 2005–2015, with a
percentage of 95.3% in Xinjiang, Sichuan, and Gansu
provinces, which remain highly endemic, especially
Xinjiang where two outbreaks were reported in the
same county (Jiashi) in 2008 and 2015 [38, 39].
Nationally, however, the prevalence is low and dimin-
ishing: 305 and 182 cases were reported in 2016 and
2017, respectively (Table 1, Fig. 2a and b) [20, 29].
The less serious form of the disease, cutaneous leish-
maniasis, has also been reported in the People’s Republic
of China, but is confined to a single isolated site; namely,
Karamay county in Xinjiang. The detection rate was
1.6% (36 per 2260) in 1992, 1.0% (14 per 1416) in 1993,
and 1.6% (24 per 1510) in 1994 in Karamay, respectively
[40]. We are not aware of more recent data.
Incidentally, the “National control plan on echinococ-
cosis and other important parasitic diseases” for the per-
iod 2016–2020 is required to also attempt decreasing
the burden of visceral leishmaniasis through detection
and treatment of cases, provision of long-lasting insecti-
cidal nets, surveillance, and integrated vector manage-
ment [41].
Helminthiases
Echinococcosis
Echinococcosis, caused by either Echinococcus granulo-
sus or E. multilocularis, is endemic in the western part
of the People’s Republic of China (Table 1 and Fig. 1c).
According to a survey carried out in 2001–2004, there
were an estimated 380 000 cases in eight provinces, with
an average prevalence of 1.1% (Fig. 2c and d) [42]. This
led to the initiation of the national echinococcosis con-
trol programme in 2005 with support from the central
government. By 2014, 254 highly endemic counties were
included in the programme [43]. A total of 666 million
Chinese Yuan (about US$ 100 million) was allocated for
the control of echinococcosis between 2010 and 2014
[43], and the number of ultrasound examinations
increased from 1.52 million to 2.13 million between
2011 and 2014. An updated survey covering the years
2012–2016 showed that the total number of estimated
cases had decreased to 166 098, with a prevalence of
0.3% in nine western provinces [44, 45]. However, 368
counties still remain endemic with cystic echinococcosis,
out of which 115 are co-endemic with alveolar echino-
coccosis [44, 45].
In the latest national control plan for the period
2016–2020, control of echinococcosis has been further
intensified, integrating the control of the transmission
source by deworming of dogs, immunization of livestock,
and screening and management of patients [41]. Thegoal set for 2020 is to reach over 70% endemic counties
reducing the prevalence to less than 1% in humans and
less than 5% in domestic dogs.
Food-borne trematodiasis
Clonorchiasis Clonorchiasis, caused by consumption of
raw or undercooked freshwater fish, is the most impor-
tant food-borne trematode infection in the People’s
Republic of China [46]. The first national survey con-
ducted in 1988–1992 estimated a national prevalence of
0.31%, which increased to 0.58% in the second national
survey done in 2001–2004 [47]. However, an additional
survey carried out in the most affected regions at the
same time, found a considerably higher prevalence of
2.4%, and hence, it was estimated that 12.5 million peo-
ple were infected with the liver fluke Clonorchis sinensis
(Fig. 2c and e) [47]. These increasing trends are felt to
be attributable to economic development, which
spurred rapid expansion of aquaculture, and hence,
freshwater fish has become a diet that can be afforded
by many more people [48]. In recent years, control
activities were adopted in the endemic areas, consisting
of chemotherapy, IEC, and improved sanitation [49,
50], which might explain the reduction in the preva-
lence to 0.47% corresponding to 6.0 million people
according to the latest national survey in 2014–2015
[51]. The most afflicted areas, with prevalence rates
over 1%, are two provinces in the south-eastern part of
the People’s Republic of China (Guangdong and
Guangxi) and two in the north-eastern part (Heilong-
jiang and Jilin) (Table 1 and Fig. 1c) [51]. Compared to
2014–2015, the national control plan for 2016–2020
aims to decrease the prevalence in all major endemic
provinces by 30% in 2020 through implementation of
an integrating control strategy, consisting of che-
motherapy, IEC, and improved sanitation [41].
Paragonimiasis
Paragonimiasis, caused by the lung fluke Paragonimus
westermani, is a common food-borne trematode infec-
tion in the People’s Republic of China [52]. P. skrjabini
is another important species that mainly occurs in the
southern parts of the People’s Republic of China. It can
cause trematode larva migrans, which helps for species-
specific diagnosis [52]. Transmission of paragonimiasis
occurs by the traditional habit of consuming raw, wine-
soaked crab meat, so called “drunken crabs” in the
southern part of the country; raw crab meat, raw crab-
sauce, or crab-jam in the south-western part of the
country; and raw crayfish and crayfish-curd in the
north-eastern part of the country [53]. A large serologi-
cal survey in eight endemic provinces between 2001 and
2004 showed a prevalence of 1.7% [42]. However, the
2014–2015 national survey based on faecal examination
Qian et al. Infectious Diseases of Poverty            (2019) 8:86 Page 7 of 16showed a crude prevalence of only 0.005% [51]. It is
conceivable that the serological survey considerably
overestimated the prevalence due to the low specificity
of this approach, particularly in view of co-endemicity
with other helminth infections. With regard to faecal
examination, it is likely to have underestimated the true
infection status due to low sensitivity. Thus, the estab-
lishment of a national endemic map for paragonimiasis
constitutes a pressing public health priority. Screening
and treatment of cases, combined with IEC, constitute
the current mainstay of control measures [53].
Fascioliasis
Fascioliasis is endemic in the northern, central, and
southern parts of the People’s Republic of China with
both Fasciola hepatica and F. gigantica reported [54,
55]. Watercress and Houttuynia cordata, which cause
the infection in humans when ingested raw, are widely
consumed in the endemic areas. A prevalence of 0.011%
was reported in the national survey conducted in 1988–
1992, with cases found in eight provinces [56], while it
decreased to 0.0007% in the national survey done in
2014–2015 [51]. Although the overall prevalence is very
low, several outbreaks have been reported recently [55,
57]. The low awareness of this infection in the public
usually leads to severe delays in the diagnosis and subse-
quent management of the disease. Currently, the surveil-
lance of outbreaks and specific public health responses
is applied in some major endemic areas (e.g. Yunnan
province in the south-western part of the People’s
Republic of China).
Lymphatic filariasis
Historically, lymphatic filariasis was endemic in the central
and south-eastern parts of the People’s Republic of China,
either caused by Wuchereria bancrofti or Brugia malayi
[13, 58]. Lymphatic filariasis was endemic in 864 counties
in 16 provinces covering a population of approximately
330 million [13, 58]. In the 1950s, the number of patients
was estimated at 31.0 million, among which 25.6 million
had microfilaraemia and 5.4 million were classified as clin-
ical cases [58, 59]. Owing to the inclusion in the National
Programme of Agricultural Development 1956–1967,
massive control activities were implemented against lym-
phatic filariasis [59]. A strategy to eliminate the transmis-
sion source through large-scale chemotherapy was
employed, based on the dearth of animal reservoirs [60].
During the period 1956–1994, there were 707.4 million
blood examinations with 23.4 million of the blood samples
tested found to have microfilaraemia [58]. Overall, there
were 260.0 million contact points for chemotherapy
(including 33.9 million by individual treatment, 31.6 mil-
lion by mass drug administration, and 194.5 million by
fortified salt) [58]. In 1994, all 864 counties reached amicrofilaria prevalence below 1% at the unit of the village,
which is considered the threshold for breaking transmis-
sion [58].
Since the early 1980s, surveillance was gradually estab-
lished at the provincial level when province-wide effec-
tive control of lymphatic filariasis had been achieved
[13]. Elimination was first announced in Guangxi in
1995 and the last province to do so was Anhui in 2006
[13]. In the same year, the Chinese government sub-
mitted its dossier for lymphatic filariasis elimination to
WHO. In 2007, WHO declared that the People’s Repub-
lic of China had succeeded to eliminate lymphatic filaria-
sis as a public health problem [13]; the first country in
the world.
Schistosomiasis
Schistosomiasis in the People’s Republic of China is
exclusively caused by infection with the species Schisto-
soma japonicum. In the 1950s, schistosomiasis was ende-
mic in 12 southern provinces, primarily along the
Yangtze River and it was estimated that 11.6 million
people were infected [61]. Over the past 60 years, schis-
tosomiasis has been the focus of concerted public health
efforts steered by the central government [62]. Four
stages of the national schistosomiasis control pro-
gramme can be distinguished: (i) the preparation stage
(1950–1955); (ii) the mass campaign stage focusing on
snail control (1956–1985); (iii) the morbidity control
stage emphasising large scale administration of prazi-
quantel, boosted by international cooperation (1986–
2003); and (iv) the current integrated strategy to block
infection transmission (since 2004) [63]. By 1989, the
prevalence and the number of cases infected with S.
japonicum decreased to 10.2% and 1.64 million, respec-
tively (Fig. 2c and d). The respective estimates for 1995
were 4.9% and 870 000, while, in 2004, the prevalence
and number of cases further declined to 2.5% and 730
000, respectively [61, 64]. Five provinces achieved trans-
mission interruption; Shanghai and Guangdong (both in
1985), Fujian (in 1987), Guangxi (in 1988), and Zhejiang
(in 1995) [65]. Especially, the successful integrated strat-
egy to control transmission source adopted in 2004 led
to a stage that can be considered pre-elimination. In
2017, it was estimated that only 37 601 cases remained
in the country (Table 1 and Fig. 1d) [66]. In addition to
the five provinces where elimination was declared, one
reached interruption of transmission, while the remain-
ing six reached transmission control in 2017 [66].
Another four provinces are targeted to achieve transmis-
sion interruption by 2020 by integrating control of
transmission sources and environmental management
[67]. Additionally, surveillance is prioritised in the
areas reaching the stage of transmission interruption
and elimination. The ambitious target set by the
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of schistosomiasis in the People’s Republic of China
by 2030 [68].
Soil-transmitted helminth infection
Soil-transmitted helminth infections occur throughout
the People’s Republic of China; yet, the most severely
affected provinces are located in the southern parts of
the country, explained by climatic and ecological fea-
tures. Over the past 30 years, a significant decrease of
soil-transmitted helminth infection has been documen-
ted unequivocally according to three national surveys.
The first survey, taking place between 1988 and 1992,
showed a prevalence of 47.0% for Ascaris lumbricoides
infection, 18.8% for Trichuris trichiura infection, and
17.2% for hookworm infection and overall infection of
any soil-transmitted helminth infection of 53.6% [56,
69]. The corresponding numbers of people infected were
estimated at 531 million, 212 million, 194 million, and
646 million, respectively (Fig. 2c) [56, 69]. In the second
national survey conducted between 2001 and 2004, the
respective prevalence rates dropped to 12.7, 4.6, 6.1, and
19.6%, with estimated numbers of people of 85.9 million,
29.1 million, 39.3 million, and 129.0 million, respectively
[42]. In the third survey carried out in 2014–2015, the
prevalence had further declined to 1.4, 1.0, 2.6, and
4.5% with the numbers of infected people estimated
at 8.8 million, 6.6 million, 17.0 million, and 29.1 mil-
lion, respectively [51]. At present, soil-transmitted
helminth infections are concentrated in the south-
western parts of the People’s Republic of China
(Table 1 and Fig. 1c) [51].
The significant decrease of soil-transmitted helminth
infection is primarily attributable to social and economic
development that spurred improved access to clean
water, sanitation, and hygiene (WASH), coupled with
other far-reaching control activities. Since the early
1990s, massive control activities were applied in schools,
including IEC, WASH, and preventive chemotherapy
[70]. Integrated community pilots, based on a multifa-
ceted control strategy similar to that implemented in the
schools, were employed in eight highly endemic counties
since 2006 [71]. The strategy proved successful in
terms of prevalence reduction, and hence, was scaled
up over the past several years [71]. According to the
national programme, the prevalence of soil-
transmitted helminth infection in the remaining high-
risk areas should decrease by another 20% by 2020
compared to 2015 [41].
Taeniasis/cysticercosis
Cysticercosis is primarily caused by larval cysts of the
tapeworm Taenia solium. Historically, the disease was
highly endemic in the People’s Republic of China,especially in the northern parts. Consequently, the Office
for Controlling and Eliminating Taeniasis and Cysticer-
cosis was established in most of the endemic provinces
during the 1970s, 1980s, and early 1990s [72]. The inte-
grated control strategy consisted of four main interven-
tions: (i) deworming people with taeniasis; (ii) inspection
of pork meat; (iii) management of human faeces and
pigs; and (iv) treatment and disposal of infected pigs
[72]. Rigorous implementation of this control strategy
resulted in a significant decrease in many provinces.
However, there is still no national endemic map avail-
able for cysticercosis.
In 2001–2004, a national serological survey was imple-
mented, which revealed a crude positive rate of 0.58%
(553/96008) [42]. Due to the low test specificity, it is
conceivable that the prevalence is considerably overesti-
mated. In view of relatively scarce data available from
hospitals, cysticercosis is concentrated in the provinces
of Yunnan and Sichuan in the south-western part of the
country, which is explained by the deeply rooted cultural
habit of raw pork consumption [73].
The national survey on intestinal parasitic diseases based
on faecal examination has clarified the situation with regard
to taeniasis in the People’s Republic of China. An overall
prevalence of 0.01% was found in 1988–1992, correspond-
ing to approximately 1.3 million cases (Fig. 2c and d) [56,
74]. The 2001–2004 survey estimated a considerably lower
number of 550 000 cases, which further decreased to 366
200 cases in 2014–2015 [42, 51]. Of note, besides T. solium,
another two species (i.e. T. saginata and T. asiatica) are co-
endemic in the People’s Republic of China [73]. In the
1988–1992 survey, using species differentiation, only 162
cases were identified as T. solium distributed across 10 pro-
vinces, notably in the north-eastern part of the country,
while 1399 cases were identified as T. saginata, distributed
across four provinces, mostly in the western part of the
country [75].
Over the past 20 years, the Office for Controlling and
Eliminating Taeniasis and Cysticercosis was gradually
scaled back due to the strong decline of cysticercosis in
many areas [72]. At present, some pilots are being car-
ried out, one in Henan province in the central part of
the People’s Republic of China, where cysticercosis was
once highly endemic [76]. Another two control pilots
were set up in the provinces of Yunnan and Sichuan in
the south-western part of the country with the aim of
supporting cysticercosis control through IEC, WASH,
screening cases with suspected taeniasis, and providing
treatment when needed.
Imported NTDs
The recent, substantial increase in population mobility,
including long-haul travels, led to importation of various
NTDs into the People’s Republic of China [77]. For
Qian et al. Infectious Diseases of Poverty            (2019) 8:86 Page 9 of 16instance, imported cases of human African trypanosomiasis
and schistosomiasis haematobia have been reported. Fortu-
nately, these diseases do not transmit within the People’s
Republic of China, owing to the absence of vectors (tsetse
fly for human African trypanosomiasis) and intermediate
hosts (snails of the genus Bulinus for schistosomiasis hae-
matobia) [78, 79]. Although no indigenous transmission of
schistosomiasis mansoni has been reported thus far, atten-
tions should be paid to the importation and current pre-
sence of the S. mansoni intermediate host Biomphalaria
straminea in the southern part of the People’s Republic of
China [78, 80].
Importation of visceral leishmaniasis cases worsens
further control and planned elimination of this disease
in the People’s Republic of China. In addition, epidemics
of dengue in neighbouring Southeast Asia constitute a
high risk for this disease also in the People’s Republic of
China, as transmission of diseases does not respect
national borders, as shown by an outbreak in the south-
ern parts of the country in 2014 [81]. Additionally, the
importation of freshwater shellfish products might cause
outbreaks of food-borne trematode infections [82].
Drives for NTDs control and elimination in the
People’s republic of China
Social and economic development
Since the 1950s, the control of schistosomiasis, leish-
maniasis, hookworm infection, and lymphatic filariasisFig. 3 Change trends of GDP per capita, sanitation, water supply, and pove
domestic productwere given high priority in the plans for national
development, while attention was also paid to leprosy
and trachoma [24]. Still today, the integrated public
health activities of the Patriotic Public Health Pro-
gramme play important roles in the control of many
infections [31]. This approach was initiated in the
early 1950s, focussing on improved sanitation and
construction of water works, while it is also tasked
with general vector control (flies, mosquitoes, cock-
roaches, and mice). For example, people living in
rural areas of the People’s Republic of China bene-
fitted from improved access to clean water, which
increased from 48.8% in 1985 to 95.8% in 2014, while
access to piped water has increased from 14.1 to
79.0% (Fig. 3) [83–86]. Although the percentage of
households with latrines in rural parts of the People’s
Republic of China reached 85.9% in 1993, the percen-
tage with clean latrines was only 7.5% which,
however, increased to 81.8% in 2017 [86, 87]. The
coverage of non-hazardous toilets (with pathogens
killed) increased from 32.3% in 2006 to 62.7% in 2017
[83, 86].
Economic development is a key driver for the control
and elimination of NTDs. The per capita gross domestic
product (GDP) has increased from 385 Chinese Yuan in
1978 to as much as 59 660 Chinese Yuan in 2017 (Fig. 3)
[88]. Nearly all NTDs are associated with poverty and
are therefore more of a problem in the least developedrty reduction in the People’s Republic of China. GDP: Gross
Qian et al. Infectious Diseases of Poverty            (2019) 8:86 Page 10 of 16areas. The population defined as living under the poverty
line in the People’s Republic of China has decreased
from 770.4 million in 1978 to 30.5 million in 2017,
which means that the rate of poverty decreased from
97.5 to 3.1% [88].
Epidemiological surveys and surveillance
Understanding the epidemiology, including the spatial
and temporal risk of NTDs, is the first step before
implementing control and elimination efforts. Several
large-scale epidemiological surveys have been carried
out, and for several NTDs, the surveys are regularly
repeated to monitor progress and identify areas that
need special attention. There is considerable granular-
ity across NTDs. For example, while county-level risk
maps have been available for leishmaniasis and lym-
phatic filariasis for several decades [13, 37], the risk
map for schistosomiasis is constantly updated, and
thus contains accurate village-level risk profiles [64,
66]. The national survey in 2012–2016 pertaining to
echinococcosis produced a county-level map [44],
while the three national surveys on intestinal
helminthiases have been updated to provide informa-
tion at the sub-provincial level for soil-transmitted
helminth infection, clonorchiasis, and taeniasis [42,
51, 56].
These epidemiological surveys take into account the
large population of the People’s Republic of China,
enrolled hundreds of thousands of participants, and
are indeed the largest in the world. For instance,
more than one million people were included in the
national survey pertaining to echinococcosis in 2012–
2016 and more than 600 000 participants were
enrolled in the third national survey for intestinal hel-
minthiases in 2014–2015. Taken together, the People’s
Republic of China has established a large surveillance
system for infectious diseases, which includes both an
active and a passive system (Table 1) [20]. Nowadays,
active population surveys cover all endemic villages
for schistosomiasis, all endemic provinces for echino-
coccosis, all indigenous endemic provinces for dengue,
several major endemic provinces for rabies, and nearly
all provinces where soil-transmitted helminth infec-
tion and clonorchiasis occur. The passive surveillance
system based on reports from national medical orga-
nisations covers all provinces, in which seven NTDs
are included, namely leprosy, dengue, rabies, leishma-
niasis, echinococcosis, lymphatic filariasis, and schisto-
somiasis [20].
Research and development
National, provincial, prefectural, and county-level anti-
infectious stations (nowadays as the Centers for Disease
Control and Prevention), have been establishedthroughout the People’s Republic of China [31]. In
addition to these four levels, many special anti-
infectious organisations were set up in the endemic
areas; specifically those targeting schistosomiasis, lym-
phatic filariasis, leishmaniasis, and leprosy. These orga-
nisations play important roles in innovating and
rigorously validating new diagnostics, drugs, and vac-
cines, as well as designing disease control strategies,
and conducting operational and implementation
research.
Particular attention is paid on the development of
novel diagnostic techniques that are adapted to the
specific stage of a disease control programme.
Usually, besides diagnosis of the pathogen, the beha-
vioural screening, serological and molecular techni-
ques are applied at different stages [89, 90]. For
example, behavioural screening should be applied at
the morbidity control stage, owing to the simplicity
and low cost, while molecular techniques are war-
ranted in the pre-elimination stage, while serology is
particularly useful in the late stages of infection and
transmission control. In line with the global NTD
control strategy put forth by WHO emphasising pre-
ventive chemotherapy, drugs and drug development
are also highly prioritised, including research on new
formulations and exploring novel implementation
strategies. Tribendimidine, developed by Chinese
scientists, has been approved for the treatment of
soil-transmitted helminth infection in the People’s
Republic of China [91]. Recently, clinical trials also
showed high efficacy of tribendimidine against C.
sinensis [92, 93]. In order to increase coverage and
compliance, new formulations have been developed.
Two prominent examples are the distribution of
diethylcarbamazine-fortified salt against lymphatic
filariasis, and the addition of sugar to anthelminthics
used against soil-transmitted helminth infections [13,
60, 94].
In addition to integrated control activities, namely
the Patriotic Public Health Programme [31], a special
strategy is usually explored for each NTD. Although
several NTDs are co-endemic in specific provinces,
the overlap might not be too extensive, depending on
the social-ecological contexts. A strategy is usually
established based on the complete understanding of
determinants, and the available techniques, human
and financial resources [63]. Pilot studies, coupled
with operational research and cost-effectiveness
considerations, are regularly implemented [60, 95].
Strategies that proved successful drive large-scale
implementation. Different strategies are usually
adopted for specific endemic situations and they are
adjusted and fine-tuned over time, based on surveil-
lance data.
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Targets
Elimination of lymphatic filariasis as a public health
problem has been achieved in 2007 (Table 2) [13].
Trachoma was announced to be eliminated as a pub-
lic health problem in 2015 [14]. On one hand, this
achievement needs to be further strengthened, while
on the other hand, its elimination needs to be verified
by WHO.
Leprosy, schistosomiasis, leishmaniasis, and rabies are
currently all in the lowest-endemic level, namely a stage
characterised by transmission control (Table 2). It is
already announced that schistosomiasis will be at the
stage of elimination by 2030 [68]. In view of achieve-
ments made thus far, this target seems eminently rea-
sonable. The progress towards the elimination of leprosy
will be further strengthened. Over 98% counties are
expected to have a prevalence < 1/100 000 by 2020 [22].
Although the targets of leishmaniasis and rabies have yet
to be defined, these two NTDs are targeted for elimina-
tion in the near future.
The soil-transmitted helminths, T. solium taeniasis/
cysticercosis, and dengue are at the stage of infection con-
trol (Table 2). This means that by 2020 the prevalence of
the soil-transmitted helminth infection in high endemic
provinces should decrease by 20% compared to that esti-
mated in 2015 [41]. Elimination pilots have been underta-
ken for T. solium taeniasis and cysticercosis [76].
Compared to other NTDs, echinococcosis and the food-
borne trematode infections are still at the stage of morbid-
ity control constituting important public health problems
in the western and eastern parts of the People’s Republic
of China, respectively (Table 2). The national goal is to
decrease the prevalence of echinococcosis to less than 1%
in humans and less than 5% in domestic dogs in over 70%
of the endemic counties by 2020. In addition, the preva-
lence of food-borne trematode infection should be
reduced with 30% in major endemic areas by 2020, as
compared to 2015 [41].
Challenges and opportunities
Although considerable progress has been achieved in the
control and elimination of NTDs since the founding of
the People’s Republic of China exactly 70 years ago, chal-
lenges remain at the onset of the Belt and Road Initiative
[96]. Due to the permissible environment and lower level
of economic development in the western parts of the
country, many NTDs remain endemic there and infra-
structure is still underdeveloped (Table 1 and Fig. 1).
The zoonotic nature of some of the NTDs, such as
rabies, echinococcosis, clonorchiasis, and taeniasis/cysti-
cercosis, holds a permanent risk of emergence. There
are deeply rooted habits of raw food consumption, such
as raw pork in western and raw freshwater fish in theeastern parts of the country [46, 76]. Economic develop-
ment usually is associated with declines of the risk of
NTDs. However, some NTD outbreaks have been linked
to people trying new dietary habits that emerged due to
enhanced socio-economic status. Urbanization and con-
centration of people in big cities increase the risk for
outbreaks of vector-borne NTDs, especially dengue [97].
Besides the importation of NTDs from other part of the
world, huge population movements within the country
confront control and elimination efforts of many NTDs.
Due to the imbalance of economic development, large
numbers of people move from less developed areas to
the big cities, which entails the transfer of some NTDs
from the western to the eastern parts of the People’s
Republic of China (e.g. schistosomiasis and leishmania-
sis) [39, 66] and when people visit their home villages,
other NTDs might come with them (e.g. dengue) [28].
Additionally, climate change should be taken seriously
as it might redraw the epidemiological maps over the
coming decades. Already, some vectors (e.g. mosquitoes
transmitting dengue) and the intermediate host snails
for schistosomiasis have started to do so [98, 99].
In 2016, the government of the People’s Republic of
China launched a plan to eliminate poverty by 2020,
which will contribute to the control and elimination
of NTDs, particularly in the least developed areas
[100]. A national plan of action, known as “Healthy
China 2030” has been established with health being
integrated into each policy enacted [101]. WASH will
be further improved. Specifically, the water supply in
rural areas will be upgraded and the coverage of non-
hazardous toilets will be increased. “Toilet revolution”
is a slogan that gained traction in recent times [102].
This approach is planned to result in the coverage of
clean toilets exceeding 85% by 2020 in rural areas,
leading to a complete coverage of non-hazardous toi-
lets for the country as a whole by 2030 [103].
Conclusions
Since the founding of the People’s Republic of China in
1949, considerable progress has been made in the con-
trol and elimination of NTDs. This not only benefits the
local communities with respect to health and wellbeing,
but also promotes progress towards ending the global
presence of the NTDs. Furthermore, experiences and
lessons in controlling and eliminating NTDs in the Peo-
ple’s Republic of China have attracted worldwide recog-
nition, and hence, innovations and control strategies are
stimulating other parts of the world, especially Africa,
Latin America, and Southeast Asia where NTDs remain
a public health problem. The inclusion of NTDs in the
Belt and Road Initiative will not only promote the global
control of NTDs but also consolidate the achievements
of this initiative.
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